233 related articles for article (PubMed ID: 26796362)
1. Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants.
Strober S
Blood; 2016 Mar; 127(12):1539-43. PubMed ID: 26796362
[TBL] [Abstract][Full Text] [Related]
2. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants.
Leventhal JR; Elliott MJ; Yolcu ES; Bozulic LD; Tollerud DJ; Mathew JM; Konieczna I; Ison MG; Galvin J; Mehta J; Badder MD; Abecassis MM; Miller J; Gallon L; Ildstad ST
Transplantation; 2015 Feb; 99(2):288-98. PubMed ID: 25594553
[TBL] [Abstract][Full Text] [Related]
3. Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation.
Scandling JD; Busque S; Shizuru JA; Lowsky R; Hoppe R; Dejbakhsh-Jones S; Jensen K; Shori A; Strober JA; Lavori P; Turnbull BB; Engleman EG; Strober S
Am J Transplant; 2015 Mar; 15(3):695-704. PubMed ID: 25693475
[TBL] [Abstract][Full Text] [Related]
4. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
Leventhal J; Abecassis M; Miller J; Gallon L; Ravindra K; Tollerud DJ; King B; Elliott MJ; Herzig G; Herzig R; Ildstad ST
Sci Transl Med; 2012 Mar; 4(124):124ra28. PubMed ID: 22399264
[TBL] [Abstract][Full Text] [Related]
5. Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.
Fehr T; Hübel K; de Rougemont O; Abela I; Gaspert A; Güngör T; Hauri M; Helmchen B; Linsenmeier C; Müller T; Nilsson J; Riesterer O; Scandling JD; Schanz U; Cippà PE
Front Immunol; 2022; 13():796456. PubMed ID: 35173720
[TBL] [Abstract][Full Text] [Related]
6. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
Leventhal JR; Ildstad ST
Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
[TBL] [Abstract][Full Text] [Related]
7. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
8. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.
Millan MT; Shizuru JA; Hoffmann P; Dejbakhsh-Jones S; Scandling JD; Grumet FC; Tan JC; Salvatierra O; Hoppe RT; Strober S
Transplantation; 2002 May; 73(9):1386-91. PubMed ID: 12023614
[TBL] [Abstract][Full Text] [Related]
9. Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.
Busque S; Scandling JD; Lowsky R; Shizuru J; Jensen K; Waters J; Wu HH; Sheehan K; Shori A; Choi O; Pham T; Fernandez Vina MA; Hoppe R; Tamaresis J; Lavori P; Engleman EG; Meyer E; Strober S
Sci Transl Med; 2020 Jan; 12(528):. PubMed ID: 31996467
[TBL] [Abstract][Full Text] [Related]
10. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
Cosimi AB; Sachs DH; Sykes M; Kawai T
Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
[TBL] [Abstract][Full Text] [Related]
11. Genomic biomarkers correlate with HLA-identical renal transplant tolerance.
Leventhal JR; Mathew JM; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
J Am Soc Nephrol; 2013 Sep; 24(9):1376-85. PubMed ID: 23787913
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review.
Annamalai C; Kute V; Sheridan C; Halawa A
Transplant Rev (Orlando); 2023 Dec; 37(4):100792. PubMed ID: 37709652
[TBL] [Abstract][Full Text] [Related]
13. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.
Opelz G; Döhler B; Middleton D; Süsal C;
Transplantation; 2017 Nov; 101(11):2789-2792. PubMed ID: 28471872
[TBL] [Abstract][Full Text] [Related]
14. Summary of the Third International Workshop on Clinical Tolerance.
Kawai T; Leventhal J; Wood K; Strober S
Am J Transplant; 2019 Feb; 19(2):324-330. PubMed ID: 30133954
[TBL] [Abstract][Full Text] [Related]
15. Megadose stem cell administration as a route to mixed chimerism.
Or-Geva N; Reisner Y
Curr Opin Organ Transplant; 2014 Aug; 19(4):334-41. PubMed ID: 24905022
[TBL] [Abstract][Full Text] [Related]
16. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.
Leventhal JR; Mathew JM; Ildstad S; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
Clin Transpl; 2013; ():145-56. PubMed ID: 25095503
[TBL] [Abstract][Full Text] [Related]
17. Limited immune tolerance induced by transient mixed chimerism.
Yu JH; Chung BH; Oh EJ; Kim JI; Kim HJ; Moon IS; Yang CW
Korean J Intern Med; 2015 Sep; 30(5):735-8. PubMed ID: 26354070
[No Abstract] [Full Text] [Related]
18. [Transplant tolerance through mixed chimerism].
Zuber J
Nephrol Ther; 2017 Apr; 13 Suppl 1():S127-S130. PubMed ID: 28577733
[TBL] [Abstract][Full Text] [Related]
19. Combined kidney and hematopoeitic cell transplantation to induce mixed chimerism and tolerance.
Lowsky R; Strober S
Bone Marrow Transplant; 2019 Aug; 54(Suppl 2):793-797. PubMed ID: 31431706
[TBL] [Abstract][Full Text] [Related]
20. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
